Top Markets
#1 Black Phoenix Black Phoenix +355.18%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +53.98%
#5 Acurast Acurast +28.90%
#6 BasedHype BasedHype +28.07%
#7 Cryptopia Cryptopia +22.67%
#8 Avantis Avantis +18.15%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.84%
#10 HOME HOME +15.01%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Clasificación en acciones #40984
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Precio por acción
$0.14627542
Capitalización bursátil
$56.32K
Cambio (1 día)
7.50%
Cambio (1 año)
2.59%
País
VG
Comercio CRISM Therapeutics Corporation (CRTX)

Categoría

Healthcare
Ganancias de CRISM Therapeutics Corporation (CRTX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di CRISM Therapeutics Corporation, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de CRISM Therapeutics Corporation desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE